Back
Karuna Therapeutics
Founded by : Andreww Miller, 1 January 2009
Suffolk County, United States
More than 250 employees
About the Company
Karuna Therapeutics, Inc. is a biopharmaceutical company that focuses on developing innovative therapies for people with disabling neuropsychiatric conditions. The company's lead program, KarXT, is a proprietary oral modulator that targets muscarinic receptors in the brain to treat acute psychosis in patients with schizophrenia and other neuropsychiatric disorders. Karuna Therapeutics also has several other programs in its pipeline for the treatment of mood disorders, cognitive disorders, and pain. The company has partnerships with major pharmaceutical companies, including Biogen and Eli Lilly, and is headquartered in Boston, Massachusetts. Karuna Therapeutics is committed to improving the lives of patients with neuropsychiatric conditions and is actively working towards bringing innovative therapies to market.
Industry Type
According to the GICS (Global Industry Classification Standard) version of March 2023, Karuna Therapeutics’s industry classification falls within the following categories:
- Sector: Health Care
- Industry group: Pharmaceuticals, Biotechnology & Life Sciences
- Industry: Biotechnology
- Sub-Industry: Biotechnology
Videos and Photos
Company Address
99 High Street, Floor 26, Boston, Massachusetts 02110, United States
Source : Google maps